Agility Training in Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

A High-Intensity Multi-Component Agility Intervention Improves Parkinson's Patients' Clinical and Motor Symptoms

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03189680
• Other study ID #: IKEB0012/2015
• Status: Completed
• Phase: N/A
• Start date: May 11, 2015
• Est. completion date: June 30, 2017

Study information

• Verified date: June 2017
• Source: Somogy Megyei Kaposi Mór Teaching Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To determine the effects of an unusually highly intensity and individualized sensorimotor and visuomotor agility exercise program on non-demented PD patients' clinical symptoms, mobility, and postural stability.

Description:

Design: Intervention study

Setting: Outpatient rehabilitation center

Participants: 55 Parkinson's disease (PD) patients completed the trial and 42 serves as comparison healthy controls

Intervention: An initial screening established specific dysfunctions of PD patients with Hoehn-Yahr stage 2-3 who were then randomly assigned to standard care (n = 20) or standard care plus at-limit intensity, individualized agility program (15 sessions, 3 weeks, n = 35).

Main outcome measures: Movement Disorder Society Unified Parkinson Disease Rating Scale, Motor Experiences of Daily Living, a measure sensitive to changes in a broad spectrum of PD symptoms

In group time, repeated measurements of variance analysis were compared to the picture parkinson's disease based on MDS-UPDRS M-EDL, Beck depression score, PDQ-39, EQ5D VAS, Schwab & England scale. The TUG test and 12 static posturographic measurements are compared and compared to the healthy group as a standard.

An at-limit and individualized sensorimotor and visuomotor agility exercise program vs. standard care, will improve non-demented, stage 2-3 PD patients' clinical symptoms, mobility, and postural stability by functionally meaningful margins.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3
• Est. completion date: June 30, 2017
• Est. primary completion date: May 31, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 55 Years to 85 Years

Eligibility

Inclusion Criteria:

• Parkinson's disease

• Hoenh Yahr scale of 2-3

• Instability problem

Exclusion Criteria:

• Severe heart problems

• Severe demeanor

• Alcoholism

• Drug problems

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• Exercise therapy
3-week-long intervention, administered daily, targeted postural instability and mobility using at-limit intensity sensorimotor and visuomotor agility training

Locations

Country	Name	City	State
Hungary	Somogy Megyei Kaposi Mór Teaching Hospital	Kaposvár	Somogy

Sponsors (2)

Lead Sponsor	Collaborator
Somogy Megyei Kaposi Mór Teaching Hospital	University Medical Center Groningen

Country where clinical trial is conducted

Hungary, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	EQ5D-5L	Questionnaire	0-5 scale (3 week-long, higher number is better)

External Links

•   Related Info